admin

Among cannabis stocks, SNDL (NASDAQ:SNDL) has been one that screens well as a value play. Even though this Canada-based integrated cannabis company isn’t cheap on a price-to-earnings basis, SNDL stock has for quite some time traded at a discount to its tangible book value. But investors who have bought it based on its low valuation
0 Comments
With inflation falling to 5%, the expectations for sustained rate hikes have fallen considerably. Even though core inflation did rise and the labor market remains strong, the Federal Reserve, for now, is unlikely to hike interest rates further. That’s great for high-cyclical growth stocks, many of which have rebounded substantially this year. However, many stocks
0 Comments
It’s fine to seek out low-priced tech stocks, but I definitely do not recommend Exela Technologies (NASDAQ:XELA) stock. Exela Technologies has financial problems and the company’s shares are at risk of being delisted from the Nasdaq exchange. So, there’s too much risk to justify an investment in Exela Technologies. Headquartered in Texas, Exela Technologies specializes in business
0 Comments
After rallying last month, Google parent Alphabet (NASDAQ:GOOG, GOOGL) has continued to hold up thus far in April. Other tech stocks have delivered a similar performance, but it may be a few company-related developments that are keeping GOOG stock on an upwards trajectory. In the past week, the tech giant has made two announcements related to how it plans to
0 Comments
Mullen Automotive (NASDAQ:MULN) stock is once again making headlines, but these latest developments aren’t being met with much excitement based on recent price action. In the past few weeks, this early-stage electric vehicle manufacturer has hit a major milestone. The company has closed on a large financing deal. Shares have barely budged on this news.
0 Comments
So, it’s settled: Canadian cannabis producer Tilray (NASDAQ:TLRY) plans to acquire rival Hexo (NASDAQ:HEXO). It’s debatable, however, whether this is actually a good idea. In the same press release, Tilray disclosed its financial results for the third quarter of fiscal 2023. Suffice it to say, the data doesn’t look promising, and it’s not a good
0 Comments
After recently reporting strong clinical data, Novavax (NASDAQ:NVAX) has tremendous opportunities in front of it. More specifically, the company’s coronavirus booster and its coronavirus-flu combination vaccine can become huge revenue generators. Given these points, I believe that NVAX stock can soar almost 12 times within the next year. The company’s new CEO also makes me very upbeat
0 Comments
In this article BRK.B Follow your favorite stocksCREATE FREE ACCOUNT J. Kempin | Getty Images Entertainment | Getty Images Warren Buffett said he was “confounded” by the opportunity to buy into five Japanese trading houses two years ago. “I was confounded by the fact that we could buy into these companies,” Buffett told CNBC’s Becky
0 Comments
Despite all the skeptics claiming that it has gone up “too far, too fast,” Nvidia (NASDAQ:NVDA) continues to climb, as investors wager that the chip maker will benefit from the artificial intelligence megatrend. Year-to-date, NVDA stock is up by nearly 93%. While another near-doubling in price may not be just around the corner, a further
0 Comments